tiprankstipranks
Sagimet Biosciences, Inc. Class A (SGMT)
NASDAQ:SGMT
US Market

Sagimet Biosciences, Inc. Class A (SGMT) Income Statement

Compare
1,144 Followers

Sagimet Biosciences, Inc. Class A Income Statement

Last quarter (Q3 2024), Sagimet Biosciences, Inc. Class A's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, Sagimet Biosciences, Inc. Class A's net income was $-14.62M. See Sagimet Biosciences, Inc. Class A’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 2.00M$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 2.00M$ -130.00K$ -134.00K$ -124.00K
Operating Expenses
$ 54.45M$ 32.74M$ 31.05M$ 23.72M$ 11.40M
Depreciation and Amortization
$ 0.00$ 0.00$ 130.00K$ 134.00K$ 124.00K
EBITDA
$ -54.45M$ -30.74M$ -30.37M$ -24.31M$ -11.25M
Operating Income
$ -54.45M$ -30.74M$ -31.05M$ -23.72M$ -11.40M
Other Income/Expenses
$ 8.89M$ 2.86M$ 556.00K$ -723.00K$ 30.00K
Pretax Income
$ -45.57M$ -27.88M$ -30.50M$ -24.44M$ -11.37M
Net Income
$ -45.57M$ -27.88M$ -30.50M$ -24.44M$ -11.37M
Per Share Metrics
Basic EPS
$ -1.45$ -2.66$ -1.38$ -1.10$ -0.51
Diluted EPS
$ -1.45$ -2.66$ -1.38$ -1.10$ -0.51
Weighted Average Shares Outstanding
31.35M 10.46M 22.17M 22.17M 22.17M
Weighted Average Shares Outstanding (Diluted)
31.35M 10.46M 22.17M 22.17M 22.17M
Currency in USD

Sagimet Biosciences, Inc. Class A Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis